Back
Novo Nordisk A/S Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Sell
33
NVO
Novo Nordisk A/S
Last Price:
$51.46
Seasonality Move:
3.96%
Sell
47
VKTX
Viking Therapeutics, Inc.
Last Price:
$36.42
Seasonality Move:
16.02%
Sell
33
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $51.47. The Score for NVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $36.46. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $51.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $36.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight selling pressure.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 57.68 | Buy |
| Chaikin Money Flow: | -10347113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.88 - 50.6) | Buy |
| Bollinger Bands (100): | (48.47 - 56.99) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.12 | Buy |
| Relative Strength Index (14 RSI): | 51.37 | Buy |
| Chaikin Money Flow: | -585164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.76 - 37.52) | Buy |
| Bollinger Bands (100): | (27.61 - 38.09) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.95 | Buy |
| 20-day SMA: | 49.04 | Buy |
| 50-day SMA: | 49.45 | Buy |
| 200-day SMA: | 60.18 | Sell |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 49.64 | Buy |
| 50-day EMA: | 50.41 | Buy |
| 200-day EMA: | 62.52 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.78 | Buy |
| 20-day SMA: | 36.31 | Buy |
| 50-day SMA: | 36.21 | Buy |
| 200-day SMA: | 30.38 | Buy |
| 8-day EMA: | 31.44 | Buy |
| 20-day EMA: | 19.84 | Buy |
| 50-day EMA: | 9.83 | Buy |
| 200-day EMA: | 2.75 | Buy |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.18 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Novo Nordisk A/S Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||